LONDON (Reuters) - The history of past drug scares suggests concerns over the safety of Sanofi-Aventis's diabetes treatment Lantus will hit sales, whether or not a suggested link to cancer proves real ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback